The Lead Episode 158: A Discussion of Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial

The Lead Episode 158: A Discussion of Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial

July 2, 2026 · 28 min · Season 4 · Episode 158

About this episode

The episode discusses device-related complications in defibrillator therapy based on the PRAETORIAN-XL Trial findings.

In this episode of The Lead , host Robert Schaller, DO, FHRS, is joined by Tina Baykaner, MD, MPH, and Maulin Shah, MD, to discuss the journal article, Device-Related Complications in Transvenous Versus Subcutaneous Defibrillator Therapy During Long-Term Follow-Up: The PRAETORIAN-XL Trial . Together, they review the study's long-term follow-up findings and explore device-related complications associated with transvenous and subcutaneous defibrillator therapy. Learning Objectives: Review the long-term follow-up results of the PRAETORIAN-XL Trial comparing transvenous and subcutaneous defibrillator therapy. Discuss device-related complications associated with transvenous and subcutaneous implantable defibrillator systems. Examine the clinical considerations of defibrillator therapy selection based on long-term device-related outcomes. Host: Robert Schaller, DO, FHRS Guests: Tina Baykaner, MD, MPH and Maulin Shah, MD Disclosures: R. Schaller Honoraria/Speaking/Consulting Fee: Philips, Abbott Medical Officer/Trustee/Director/Committee Chair/Other Fiduciary Role: Imricor Other Financial Relationship: Other T. Baykaner Honoraria/Speaking/Consulting Fee: Volta Medical, Medtronic…

More episodes of The Lead Podcast presented by Heart Rhythm Society

Explore listener stats, chart rankings, contacts and more on the The Lead Podcast presented by Heart Rhythm Society podcast page.